Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18508
Country/Region: Kenya
Year: 2017
Main Partner: Centre for Health Solutions
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $10,669,097 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $578,384
Testing: HIV Testing and Counseling (HVCT) $2,275,400
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $893,651
Treatment: Adult Treatment (HTXS) $6,226,133
Treatment: Pediatric Treatment (PDTX) $695,529
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 328
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 72
GEND_GBV <10, Male, Physical and/or Emotional Violence 2018 310
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2018 68
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 331
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 76
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 183
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2018 39
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 255
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 56
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 182
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 37
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 357
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 84
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 108
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 22
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 5,722
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 1,524
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 1,680
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 451
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 1,909
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2018 510
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2018 976
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2018 249
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,312
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 12,381
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 3,314
GEND_GBV Number of people receiving post-GBV care 2018 15,695
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 846,057
HTS_TST Service Delivery Point (Facility) ANC: 1-9, Negative 2018 1
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 109
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 8,348
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 24,456
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 34,524
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 23
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 588
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 382
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 281
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 1,750
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 907
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 2,912
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 988
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 6,980
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 3,108
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 1,636
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 1,053
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 20,261
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 12,704
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 9,557
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 61,734
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 31,883
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 100,838
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 34,070
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 242,336
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 107,252
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 55,970
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 35,881
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 27,279
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 125
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 92
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 40
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 354
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 175
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 591
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 202
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 1,296
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 611
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 319
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 192
HTS_TST Sum of Test Result disaggregates 2018 14,264
HTS_TST_POS By Test Result: Positive 2018 14,264
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 382
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 692
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 139
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 85
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 164
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 324
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 102
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 1,012
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 240
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 5,483
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 3,154
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 1,076
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 630
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 200
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 148
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 77
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 6
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,289
PMTCT_ART New on ART 2018 1,151
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 2,440
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 69,934
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 2,440
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 546
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,801
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 55
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 38
PMTCT_STAT By Age (Numerator): 10-14 2018 111
PMTCT_STAT By Age (Numerator): 15-19 2018 8,457
PMTCT_STAT By Age (Numerator): 20-24 2018 25,116
PMTCT_STAT By Age (Numerator): 25-49 2018 36,241
PMTCT_STAT By Age (Numerator): 50+ 2018 9
PMTCT_STAT By Number of known positives: 15-19 2018 37
PMTCT_STAT By Number of known positives: 20-24 2018 268
PMTCT_STAT By Number of known positives: 25-49 2018 989
PMTCT_STAT By Number of known positives: 50+ 2018 12
PMTCT_STAT By Number of new negative: 10-14 2018 103
PMTCT_STAT By Number of new negative: 15-19 2018 8,205
PMTCT_STAT By Number of new negative: 20-24 2018 24,056
PMTCT_STAT By Number of new negative: 25-49 2018 34,384
PMTCT_STAT By Number of new negative: 50+ 2018 785
PMTCT_STAT By Number of new positives: 15-19 2018 45
PMTCT_STAT By Number of new positives: 20-24 2018 365
PMTCT_STAT By Number of new positives: 25-49 2018 683
PMTCT_STAT By Number of new positives: 50+ 2018 2
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 69,934
PMTCT_STAT_den By Age (Denominator): <15-19 2018 8,458
PMTCT_STAT_den By Age (Denominator): 10-14 2018 110
PMTCT_STAT_den By Age (Denominator): 20-24 2018 25,114
PMTCT_STAT_den By Age (Denominator): 25-49 2018 36,246
PMTCT_STAT_den By Age (Denominator): 50+ 2018 6
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 28
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 397
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 60
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 893
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,378
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,378
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 28
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 397
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 60
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 893
TB_PREV By Age/Sex (Numerator): <15, Female 2018 297
TB_PREV By Age/Sex (Numerator): <15, Male 2018 257
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 8,328
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 3,718
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 12,600
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 12,600
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 14,651
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 352
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 371
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 9,680
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 4,242
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 14,651
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 113
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,505
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 185
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 3,249
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 5,052
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 5,138
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 115
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,526
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 196
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 3,301
TX_CURR Age/Sex: <1 2018 39
TX_CURR Age/Sex: <1-9 2018 2,637
TX_CURR Age/Sex: 10-14 Female 2018 1,402
TX_CURR Age/Sex: 10-14 Male 2018 1,277
TX_CURR Age/Sex: 15-19 Female 2018 1,429
TX_CURR Age/Sex: 15-19 Male 2018 1,021
TX_CURR Age/Sex: 20-24 Female 2018 1,901
TX_CURR Age/Sex: 20-24 Male 2018 627
TX_CURR Age/Sex: 25-49 Female 2018 30,830
TX_CURR Age/Sex: 25-49 Male 2018 9,141
TX_CURR Age/Sex: 50+ Female 2018 10,521
TX_CURR Age/Sex: 50+ Male 2018 5,380
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 66,205
TX_CURR Sum of age/sex disaggregates 2018 2,450
TX_NEW Breastfeeding status 2018 91
TX_NEW By Age/Sex: <1 2018 54
TX_NEW By Age/Sex: 1-9 2018 433
TX_NEW By Age/Sex: 10-14 Female 2018 79
TX_NEW By Age/Sex: 10-14 Male 2018 71
TX_NEW By Age/Sex: 15-19 Female 2018 355
TX_NEW By Age/Sex: 15-19 Male 2018 115
TX_NEW By Age/Sex: 20-24 Female 2018 1,346
TX_NEW By Age/Sex: 20-24 Male 2018 344
TX_NEW By Age/Sex: 25-49 Female 2018 6,657
TX_NEW By Age/Sex: 25-49 Male 2018 3,025
TX_NEW By Age/Sex: 50+ Female 2018 1,255
TX_NEW By Age/Sex: 50+ Male 2018 858
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 14,592
TX_NEW Pregnancy status 2018 898
TX_NEW Sum of Age/Sex disaggregates 2018 14,105
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 66,205
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 59,053
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,997
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 144
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,914
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 133
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 37,537
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,835
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 13,463
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,029
TX_PVLS Numerator: Indication: Routine 2018 54,912
TX_PVLS Numerator: Indication: Targeted 2018 4,141
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 93
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 93
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2,537
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 1,237
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,563
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 188
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,428
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 179
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 41,250
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,150
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 15,312
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,135
TX_PVLS_den Denominator: Indication: Routine 2018 61,552
TX_PVLS_den Denominator: Indication: Targeted 2018 4,653
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 148
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 101
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,201
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 913
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 775
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 747
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,172
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,316
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 14,010
TX_RET Numerator by Status: Breastfeeding 2018 98
TX_RET Numerator by Status: Pregnant 2018 919
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 14,777
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 812
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 777
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,710
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,478
TX_RET_den Denominator by Status: Breastfeeding 2018 98
TX_RET_den Denominator by Status: Pregnant 2018 914
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 66,205
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 551
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 1
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 10
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 177
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 363
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 2,767
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 2,620
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 44,646
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 16,172
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 13,241
TX_TB_den Denominator: By Screen Result: Negative 2018 52,959
TX_TB_den Denominator: By Screen Result: Positive 2018 13,246
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 13,241
Cross Cutting Budget Categories and Known Amounts Total: $158,000
Gender: Gender Based Violence (GBV) $158,000
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building